Offer - Urjas Oil for just ₹ 1 X
Shaltop A, a prescription drug, is manufactured in various forms such as Solution. Other than this, Shaltop A has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Shaltop A is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Shaltop A are Flushing, Bloating or fullness, Weight gain. While these are the most often observed Shaltop A side effects, there are can be others also. These have been listed below. Normally, these side effects of Shaltop A are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Shaltop A has a Moderate effect for pregnant women and Severe effect on lactating mothers. It is important to know if Shaltop A has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Shaltop A related warnings section.
Shaltop A is not recommended if you suffer from certain medical conditions as it can have adverse effects. Asthma, Heart Failure, Pulmonary Hypertension are examples of such conditions. Other contraindications of Shaltop A have been discussed in the sections ahead.
Additionally, Shaltop A may also adversely react with other medicines. See below for a complete list.
You should also be aware that Shaltop A is not safe while driving, and is not addiction.
Shaltop A is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Shaltop A safe for pregnant women?
Shaltop A can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Shaltop A right away. Take your doctor's advice before taking it again.
Is the use of Shaltop A safe during breastfeeding?
Shaltop A may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Shaltop A on the Kidneys?
In the absence of any scientific study on the side effects of Shaltop A on kidney, information on safety of Shaltop A for kidney is unavailable.
What is the effect of Shaltop A on the Liver?
The liver can be affected by Shaltop A. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Shaltop A only after medical advice.
What is the effect of Shaltop A on the Heart?
Shaltop A is not harmful for the heart.
Shaltop A should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Shaltop A unless your doctor advises you to do so -
Is this Shaltop A habit forming or addictive?
Shaltop A does not cause addiction.
Interaction between Food and Shaltop A
You can take Shaltop A with food.
Interaction between Alcohol and Shaltop A
It is difficult to say anything about the effect of Shaltop A and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azelaic acid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 892-893
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 567
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Loniten® (minoxidil)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A Micro (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renova® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vesanoid® (tretinoin)